Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
13.37
-0.24 (-1.76%)
Apr 29, 2026, 9:43 AM EDT - Market open
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $1.38 billion as of April 29, 2026. Its market cap has increased by 40.71% in one year.
Market Cap
1.38B
Enterprise Value
580.75M
1-Year Change
40.71%
Ranking
Category
Stock Price
$13.37
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $1.38B, an increase of 3,871.39%. That is a compound annual growth rate of 36.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.39B | -53.17% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.46B |
| Immunocore Holdings | 1.46B |
| Damora Therapeutics | 1.46B |
| Agios Pharmaceuticals | 1.45B |
| Wave Life Sciences | 1.45B |
| Biohaven | 1.45B |
| Bicara Therapeutics | 1.44B |
| Maze Therapeutics | 1.43B |